Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 4
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| capsule | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| aveo pharmaceuticals, inc. | 2 |
Exclusivity
Patents and exclusivities
4| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 7166722 | FOTIVDAtivozanib hydrochloride | substance, product | Nov 2028 |
| 11504365 | FOTIVDAtivozanib hydrochloride | use | Nov 2039 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| FOTIVDA | Tivozanib | capsule, oral | 45629-089NDA |
| FOTIVDA | Tivozanib | capsule, oral | 45629-134NDA |
Compare
Other companies listing tivozanib
- Catalent Pharma Solution, LLC0 sites · 12 NDC
Enquiry
Common questions
- Is AVEO Pharmaceuticals, Inc. FDA approved?
- AVEO Pharmaceuticals, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does AVEO Pharmaceuticals, Inc. make?
- 2 products are listed under AVEO Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as capsule. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.